AIG
VTYX

American International Group’s Ventyx Biosciences VTYX Stock Holding History

American International Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,064
Closed -$127K – 2678
2024
Q1 		$127K Sell
23,064
-198
-0.9% -$905 ﹤0.01% 2387
2023
Q4 		$57.5K Sell
23,262
-95
-0.4% -$902 ﹤0.01% 2784
2023
Q3 		$811K Buy
23,357
+831
+4% +$28.7K 0.01% 1341
2023
Q2 		$739K Buy
22,526
+10,491
+87% +$362K ﹤0.01% 1410
2023
Q1 		$403K Buy
12,035
+240
+2% +$9.33K ﹤0.01% 1722
2022
Q4 		$387K Buy
11,795
+1,154
+11% +$34.2K ﹤0.01% 1744
2022
Q3 		$371K Buy
10,641
+151
+1% +$3.34K ﹤0.01% 1768
2022
Q2 		$128K Buy
10,490
+5,305
+102% +$79.3K ﹤0.01% 2446
2022
Q1 		$70K Sell
5,185
-366
-7% -$4.89K ﹤0.01% 2731
2021
Q4 		$110K Buy
+5,551
New +$105K ﹤0.01% 2675

Other funds holding VTYX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American International Group's VTYX Position: Q2 2024 in Review

American International Group sold out of Ventyx Biosciences (VTYX) in Q2 2024, closing a stake of 23,064 shares — an estimated $127K sold.

American International Group first reported a position in VTYX in Q4 2021 and held it in 10 quarters. The position peaked at $811K in Q3 2023. 117 funds tracked by Wall St. Rank hold VTYX as of Q2 2024.

  • American International Group reported no remaining Ventyx Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 23,064 Ventyx Biosciences shares in Q2 2024, an estimated $127K.
  • American International Group first reported a position in Ventyx Biosciences in Q4 2021 and held it in 10 quarters.
  • American International Group's Ventyx Biosciences position peaked at $811K in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.